1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CAPR SPEC
  6. Financials
    CPSR   US14070Y1010

CAPR SPEC

(CPSR)
Delayed Nyse  -  04:00 2022-08-09 pm EDT
1.440 USD   +6.67%
04/22Capstar Special Purpose Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
01/20CAPR SPEC27 : Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar - Form 8-K
PU
01/14Health Care Stocks Unable to Pare All of Their Earlier Decline by Friday Close
MT
SummaryQuotesChartsNewsCompanyFinancials 
Valuation
Fiscal Period: December 2020 2021
Capitalization1 350344
Enterprise Value (EV)1 350343
P/E ratio --26,6x
Yield --
Capitalization / Revenue --
EV / Revenue --
EV / EBITDA --
Price to Book 70,0x-6,42x
Nbr of stocks (in thousands) 34 50034 500
Reference price () 10,29,96
Announcement Date 03/31/202104/22/2022
1 USD in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2020 2021
Net sales --
EBITDA --
Operating profit (EBIT) --20,7
Operating Margin --
Pre-Tax Profit (EBT)1 -2,42-12,9
Net income1 -2,42-12,9
Net margin --
EPS --0,37
Dividend per Share --
Announcement Date 03/31/202104/22/2022
1 USD in Million
Balance Sheet Analysis
Fiscal Period: December 2020 2021
Net Debt1 --
Net Cash position1 0,490,22
Leverage (Debt / EBITDA) --
Free Cash Flow -7,31
ROE (Net Profit / Equities) -27,4%
Shareholders' equity1 --47,1
ROA (Net Profit / Asset) --4,67%
Assets1 -276
Book Value Per Share2 0,14-1,55
Cash Flow per Share2 0,010,01
Capex --
Capex / Sales --
Announcement Date 03/31/202104/22/2022
1 USD in Million
2 USD